A ‘cure’ for haemophilia is one step closer, following results of a groundbreaking gene therapy trial led by the NHS in London.
Clinical researchers at Barts Health NHS Trust and Queen Mary University of London have found that over one year on from a single treatment with a gene therapy drug, participants with haemophilia A (the most common type) are showing normal levels of the previously missing protein, and effectively curing them.
A single infusion of the gene therapy drug showed improved levels of the essential blood clotting protein Factor VIII, with 85 per cent of patients achieving normal or near-normal Factor VIII levels even many months after treatment.
The ‘transformational’ results have particular significance as the first successful gene therapy trial for the haemophilia A.
A hereditary genetic condition
There are around 2000 people with severe haemophilia A in the UK. A hereditary genetic condition dominantly affecting men, people with severe haemophilia A have virtually none of the protein factor VIII which is essential for blood to clot. It puts those affected at risk of excessive bleeding even from the slightest injury as well as causing spontaneous internal bleeding, which can be life-threatening. Recurring bleeding into joints can also lead to progressive joint damage and arthritis. The only current treatment involves multiple weekly injections to control and prevent bleeding, but there is no cure.
The trial saw patients across England injected with a copy of the missing gene, which allows their cells to produce the missing clotting factor. Following patients for up to nineteen months, tests show that eleven out of thirteen patients in the trial now have normal or near normal levels of the previously missing factor and all thirteen patients have been able to stop their previously regular treatment.
Professor John Pasi, Haemophilia Centre Director at Barts Health NHS Trust and Professor of Haemostasis and Thrombosis at Queen Mary University of London explained: “We have seen mind-blowing results which have far exceeded our expectations. When we started out we thought it would be a huge achievement to show a five per cent improvement, so to actually be seeing normal or near normal factor levels with dramatic reduction in bleeding is quite simply amazing. We really now have the potential to transform care for people with haemophilia using a single treatment for people who at the moment must inject themselves as often as every other day. It is so exciting.”
The team will now hold further tests widening participants globally to include people in the USA, Europe, Africa and South America.
Professor Pasi continued: “Incredibly exciting is the potential for a significant change in how haemophilia is treated globally. A single dose of medication that can so dramatically improve the lives of patients across the world is an amazing prospect.”
Professor Jo Martin, President, The Royal College of Pathologists said: “Pathology research is often responsible for ground-breaking developments in diagnoses and treatments that transform the lives of patients.
“What is truly remarkable about this revolutionary new gene therapy are the profound life-changing effects it offers patients with haemophilia. We would like to congratulate College fellow, Professor Pasi, and his team at Barts Health NHS Trust and Queen Mary University of London for their work in creating a simple but transformational treatment for patients.”
Jake Omer, 29 lives in Billericay and is married with two children, aged 3 years and a baby of 5 weeks. Diagnosed at two years old, he has had frequent injections of factor VIII to prevent bleeds ever since. Before he was treated with the gene therapy, Jake would wake up early before work to inject three times a week as well as injecting whenever he had an injury to stop the bleeding. As a result of of repeated bleeding Jake has arthritis in his ankles. His father is a Turk-Cypriot and as a child he and his family could never travel to visit relatives in case he needed medical care as the facilities wouldn’t have been available.
Jake said: “The gene therapy has changed my life. I now have hope for my future. It is incredible to now hope that I can play with my kids, kick a ball around and climb trees well into my kids’ teenage years and beyond. The arthritis in my ankles meant I used to worry how far I would be able to walk once I turned 40. At 23 I struggled to run 100m to catch a bus; now at 29 I’m walking two miles every day which I just couldn’t have done before having the gene therapy treatment.
“It’s really strange to not have to worry about bleeding or swellings. The first time I noticed a difference was about four months after the treatment when I dropped a weight in the gym, bashing my elbow really badly. I started to panic thinking this is going to be really bad, but after icing it that night I woke up and it looked normal. That was the moment I saw proof and knew that the gene therapy had worked.”
The Latest on: Haemophilia
Can stem cell therapy help in treating haemophilia?
on April 18, 2018 at 5:56 am
Haemophilia is a bleeding disorder where the blood doesn’t form clots. It is a genetic disorder where the blood doesn’t have enough clotting factor. There is no definite cure for this disorder. However, with various therapies and medication, especially ... […]
Stunning mural highlighting haemophilia unveiled in Dublin
on April 18, 2018 at 4:50 am
A stunning mural has been unveiled in Dublin to mark World Haemophilia Week and the 50th anniversary of the Irish Haemophilia Society (IHS). Contemporary artist Shane O'Malley has created the patient-inspired mural to help to raise awareness of the blood ... […]
Roche haemophilia drug gets fast FDA review in expanded use
on April 17, 2018 at 4:31 am
The FDA has granted ‘Breakthrough Therapy’ status for Roche’s Hemlibra (emicizumab) for people with haemophilia A without factor VIII inhibitors, as the Swiss firm aims to take market share from rivals including Shire. Roche’s Genentech unit said ... […]
World Haemophilia Day: Foods That May Help Manage Hemophilia
on April 17, 2018 at 3:44 am
World Heritage Site Qutub Minar, in the heart of Delhi, was lit up red on Monday night to mark the World Haemophilia Day, which is observed on 17th April every year by the World Federation of Haemophilia (WFH). The monument will continue to be red on ... […]
World Hemophilia Day 2018: Haemophilia awareness program, Haem Utsav, held in Delhi
on April 17, 2018 at 3:21 am
On the occasion of World Haemophilia Day, the Haemophilia Day Care Centre (HDCC) of Delhi Government at Maulana Azad Medical College (MAMC) and Lok Nayak Hospital (LNH) jointly conducted a one-day patient awareness program-‘Haem Utsav, e-learning to ... […]
World Haemophilia Day 2018: Foods That May Help Manage Haemophilia
on April 17, 2018 at 1:50 am
World Heritage Site Qutub Mina, in the heart of Delhi, was lit up red on Monday night to mark the World Haemophilia Day, which is observed on 17th April every year by the World Federation of Haemophilia (WFH). The monument will continue to be red on ... […]
World Haemophilia Day: Replacement therapy at young age can avert disability among patients
on April 17, 2018 at 1:41 am
On April 17, World Haemophilia Day, let us pledge to work towards making haemophilia in India disability free. By Dr Naresh Gupta Once considered as a 'royal' disease because of its association with the family of Queen Victoria, haemophilia is a blood ... […]
Haemophilia Day focuses on disease awareness
on April 16, 2018 at 6:26 pm
Steps on to have state adopt prophylaxis as treatment policy. KOCHI: With the 28th World Haemophilia Day falling on Tuesday, the focus is now moving to increase awareness among the public, patients, caregivers, officials and policy makers about the disease ... […]
World Haemophilia Day 2018: Theme, Importance, Significance and Celebration for Healthy Living
on April 16, 2018 at 10:12 am
World Haemophilia Day is recognized worldwide on 17th April every year to increase awareness of haemophilia and other inherited bleeding disorders. It was started by the World Federation of Haemophilia (WHF). This is a critical effort since with increased ... […]
'Many haemophilia cases go undiagnosed'
on April 13, 2018 at 9:25 pm
MYSURU: Pointing to the availability of free treatment for patients suffering from haemophilia, Karnataka's blood cell nodal officer Dr Swatantra R Bankar on Friday said, "No patient in Karnataka will face problems since medicines are available at all ... […]
via Google News and Bing News